Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicabili
ty in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. CVIA also welcomes commentaries, case studies and reports, letters to the editor, methodology papers related to clinical trials, education and training articles, techniques and videos. CVIA was founded on the occasion of the 25th anniversary of the GW-ICC in 2014 by Professor Dayi Hu, president of the GW-ICC and past president of the Chinese Society of Cardiology, and C. Richard Conti, MD, a past president of the American College of Cardiology and former Editor of Clinical Cardiology. The GW-ICC is one of the largest congresses in the Asian-Pacific region and is the most comprehensive and influential academic conference on cardiology. Held as a regular annual conference since 1990, GW-ICC has provided a platform for continuing education in cardiovascular disease diagnosis, treatment, and technology training, through events that leverage the expertise of internationally renowned cardiologists and scholars from the United States, Europe and Asia. The journal is published by Compuscript on behalf of the World Journals (Beijing) Medical Technology Co., Ltd. Compuscript is an international company based in Shannon, Ireland.
